Leslie Citrome

64PUBLICATIONS
199CO-AUTHORS
PharmacogenomicsEpidemiological modellingPsychological methodology, design and analysisPharmacology and pharmaceutical sciences not elsewhere classifiedPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Oct 22, 2026
Healthcare utilization and costs associated with dextromethorphan-bupropion versus selected other branded treatments for major depressive disorder: a US real-world study.

|Aug 26, 2026
What to Expect in 2026-2027: Important Health Economics and Outcomes Research Topics.

|Jun 12, 2026
Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.

|May 14, 2026
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm.

|Mar 30, 2026
The Clinically Meaningful Score Difference and Meaningful Score Regions in Positive and Negative Syndrome Scale Total Score from Post Hoc Analyses of a Phase 3 Pivotal Clinical Trial of Transdermal Asenapine in Patients with Schizophrenia.

Leslie Citrome, Pál Czobor, Marina Komaroff

|Feb 25, 2026
Prescriber- and Patient-Level Characteristics Associated with Patient Adherence to Any Antipsychotics Among Patients with Schizophrenia in the United States.

Arthur Voegel, Ronaldo R Naranjo, Lilian Diaz

Pageof 11

Frequent Collaborators

8 joint publications

Christoph U Correll

7 joint publications

John M Kane

4 joint publications

Ian R McGrane

4 joint publications

Robert O Cotes